XTX Topco Ltd lifted its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 150.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 24,748 shares of the company's stock after buying an additional 14,880 shares during the quarter. XTX Topco Ltd owned about 0.05% of Azenta worth $1,199,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the stock. Farther Finance Advisors LLC lifted its stake in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock worth $74,000 after buying an additional 256 shares during the last quarter. Arizona State Retirement System lifted its stake in shares of Azenta by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 14,050 shares of the company's stock worth $739,000 after buying an additional 269 shares during the last quarter. Green Alpha Advisors LLC lifted its stake in shares of Azenta by 3.5% during the 3rd quarter. Green Alpha Advisors LLC now owns 10,203 shares of the company's stock worth $494,000 after buying an additional 348 shares during the last quarter. QRG Capital Management Inc. lifted its stake in shares of Azenta by 6.6% during the 3rd quarter. QRG Capital Management Inc. now owns 6,156 shares of the company's stock worth $298,000 after buying an additional 383 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its stake in shares of Azenta by 3.2% during the 3rd quarter. Handelsbanken Fonder AB now owns 12,981 shares of the company's stock worth $629,000 after buying an additional 400 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.
Analysts Set New Price Targets
Several analysts have weighed in on AZTA shares. Evercore ISI dropped their price objective on shares of Azenta from $53.00 to $50.00 and set an "in-line" rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC dropped their price objective on shares of Azenta from $69.00 to $55.00 and set a "buy" rating for the company in a research note on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Azenta presently has a consensus rating of "Hold" and a consensus price target of $63.60.
Check Out Our Latest Research Report on AZTA
Insider Activity at Azenta
In other news, CEO John Marotta purchased 12,717 shares of the company's stock in a transaction dated Monday, November 18th. The shares were purchased at an average price of $39.48 per share, for a total transaction of $502,067.16. Following the transaction, the chief executive officer now owns 99,612 shares of the company's stock, valued at approximately $3,932,681.76. This trade represents a 14.63 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Herman Cueto sold 1,595 shares of the business's stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the transaction, the chief financial officer now owns 24,604 shares in the company, valued at $1,074,702.72. This trade represents a 6.09 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 3,018 shares of company stock valued at $126,689. 1.77% of the stock is owned by insiders.
Azenta Stock Down 1.0 %
Shares of NASDAQ:AZTA traded down $0.48 during midday trading on Tuesday, hitting $46.36. The stock had a trading volume of 326,105 shares, compared to its average volume of 559,600. The company's 50-day moving average price is $44.69 and its 200-day moving average price is $49.67. The company has a market capitalization of $2.11 billion, a P/E ratio of -15.61 and a beta of 1.49. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16.
Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million during the quarter, compared to analysts' expectations of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.13 EPS. Research analysts expect that Azenta, Inc. will post 0.41 EPS for the current fiscal year.
Azenta Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.